Delivery Order SPE2DB22D2211-SPE2DB26FRHLX
- Not listed
- The Defense Logistics Agency awarded a $39,167.67 delivery order to AmerisourceBergen Drug Corp for TALTZ 80 mg/ml auto-injector (2-pack) pharmaceutical products on October 22, 2025, with completion targeted for October 23, 2025. This firm fixed-price delivery order represents a non-set-aside, competitively awarded procurement supporting federal medical supply requirements. The work will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $6,641.24 on August 20, 2025, for the supply of TALTZ 80 mg/ml autoinjector medication. This is a firm fixed price, non-set-aside contract with a completion date of August 21, 2025, and performance location in Conshohocken, Pennsylvania, where the vendor maintains its corporate headquarters. The delivery order represents a single transaction under AmerisourceBergen's larger pharmaceutical supply framework...
- The Defense Logistics Agency (DLA) awarded a $16,873.06 delivery order to AmerisourceBergen Drug Corp for the supply of TALTZ 80 mg/ml autoinjector medication, with a completion date of October 29, 2025. This competitive award uses firm fixed pricing and represents a non-set-aside procurement. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and operates as a major pharmaceutical distributor serving federal medical...
- The Defense Logistics Agency awarded a $15,731.15 delivery order to AmerisourceBergen Drug Corp on October 23, 2025, for the supply of TALTZ 80 mg/ml autoinjector medication. This is a firm fixed price, non-set-aside contract with an ultimate completion date of October 24, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $1,660.30 to AmerisourceBergen Drug Corp for TALTZ 80 MG/ML Autoinjector on September 3, 2025, with completion scheduled for September 4, 2025. This competitively awarded, firm fixed-price delivery order contains no set-aside designation and represents a single transaction under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. The product will be delivered to the contractor's facility in...
- The Defense Logistics Agency awarded a $22,497.98 delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for TALTZ 80 mg/ml autoinjector supply. This is a firm fixed price, non-set-aside contract with a completion date of August 15, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $5,408.43 for TALTZ 80 MG/ML AutoInjector on October 29, 2025, with an ultimate completion date of October 30, 2025. This firm fixed price, competitively awarded delivery order represents a child contract under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion pharmaceutical prime vendor agreement running through December 2026. The delivery...
- The Defense Logistics Agency awarded a delivery order valued at $21,929.06 to AmerisourceBergen Drug Corp for the supply of TALTZ 80 MG/ML Autoinjector, with an ultimate completion date of July 25, 2025. This competitively awarded, non-set-aside contract employs firm fixed pricing and represents a single delivery order transaction. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $22,134.58 delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of TALTZ 80 mg/ml autoinjector medication. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 9, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $17,228.37 on August 11, 2025, for the supply of TALTZ 80 MG/ML AutoInjector (2-pack). This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 12, 2025, with performance at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The contract utilizes no set-aside provisions and represents a routine pharmaceutical procurement through established federal...
- SPE2DB22D2211Indefinite Delivery Contract
- SPE2DB22D2211-SPE2DB26FRHLXDelivery Order
The Defense Logistics Agency awarded a $8,565.85 firm fixed price delivery order to AmerisourceBergen Drug Corp for TALTZ 80 mg/mL autoinjector medication, with an ultimate completion date of November 3, 2025. This non-set-aside contract represents a single delivery order under AmerisourceBergen's larger pharmaceutical supply relationship with the federal government. The product will be delivered to the contractor's location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary distribution operations. This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a comprehensive $999,999,999.00 global pharmaceutical support vehicle running through December 2026 designated as SPE2DX. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen supplies a broad range of medications and medical supplies to support military healthcare systems and the Defense Health Agency. The company has demonstrated consistent capability to fulfill federal medical procurement requirements through competitive open competition, with its extensive contract portfolio spanning specialty medications, brand-name and generic drugs, vaccines, and specialized medical devices across multiple therapeutic domains for military and veteran healthcare systems worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.6k | 10/31/25 |